Evoke Pharma (NASDAQ:EVOK) Stock Price Passes Below 200 Day Moving Average of $5.74

Shares of Evoke Pharma, Inc. (NASDAQ:EVOK) passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $5.74 and traded as low as $4.73. Evoke Pharma shares last traded at $4.95, with a volume of 38,468 shares traded.

Analyst Ratings Changes

Separately, StockNews.com began coverage on Evoke Pharma in a research note on Thursday. They set a “sell” rating for the company.

Evoke Pharma Stock Up 1.6 %

The business’s fifty day moving average is $4.83 and its two-hundred day moving average is $5.74. The stock has a market capitalization of $42.56 million, a PE ratio of -2.70 and a beta of 0.38.

Evoke Pharma (NASDAQ:EVOK) last issued its quarterly earnings data on Tuesday, August 13th. The specialty pharmaceutical company reported ($0.93) EPS for the quarter, missing analysts’ consensus estimates of ($0.72) by ($0.21). Evoke Pharma had a negative return on equity of 964.25% and a negative net margin of 86.74%. The business had revenue of $2.55 million during the quarter.

About Evoke Pharma

Evoke Pharma, Inc, a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults.